檳傑科達(01665.HK)前三季度經調整純利增長30.2%至9539.7萬令吉
格隆匯11月7日丨檳傑科達(01665.HK)發佈公告,發佈三季度業績,截至2019年9月30日止九個月,公司實現經營收入3.62億令吉,同比增長18.5%;毛利1.31億令吉,同比增長33.3%;經調整期內溢利9539.7萬令吉,同比增長30.2%;基本每股盈利5.96仙。
公告表示,截至2019年9月30日止九個月,集團錄得收益較去年同期增加18.5%。期內集團的收益來自自動化測試設備及廠房自動化解決方案兩個分部,該等分部的貢獻分別佔集團總收益約86.8%及13.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.